Stockholders’ Equity (Details)								9 Months Ended
	Jun. 30, 2022 USD ($) $ / shares shares	Jun. 16, 2022 USD ($) shares	Jun. 15, 2022 USD ($) shares	Jun. 02, 2022 USD ($)	May 30, 2022 $ / shares shares	May 09, 2022	Apr. 06, 2022 USD ($) $ / shares shares	Sep. 30, 2022 USD ($) $ / shares shares	Sep. 30, 2021 USD ($)	Apr. 08, 2022 USD ($)	Dec. 31, 2021 $ / shares shares
Class of Stock [Line Items]
Reverse stock split						0.09
Stock issuance costs | $				$ 100,000				$ 106,000	$ 0
Proceeds from sale of equity, net | $				14,900,000
Preferred shares, shares authorized (in shares) | shares								2,000,000			2,000,000
Preferred shares, par value (in dollars per share) | $ / shares								$ 0.0001			$ 0.0001
Preferred shares, shares issued (in shares) | shares								15,000			0
Preferred shares, shares outstanding (in shares) | shares								15,000			0
Common shares, shares authorized (in shares) | shares								170,000,000			170,000,000
Common shares, par value (in dollars per share) | $ / shares								$ 0.0001			$ 0.0001
Common shares, shares outstanding (in shares) | shares								11,152,673			8,544,225
Common shares, shares issued (in shares) | shares								11,152,673			8,544,225
Proceeds from the issuance of common stock | $				2,000,000				$ 15,016,000	$ 0
Proceeds from issuance of warrants | $				$ 12,900,000
Registered Direct Offering Warrants
Class of Stock [Line Items]
Number of shares of common stock for which warrant is exercisable (in shares) | shares					7,788,480
Discount from stock price (dollars per share) | $ / shares					$ 0.0001
Exercise price of warrant (in dollars per share) | $ / shares					$ 0.0001
Ownership threshold					9.99%
Pre-funded warrants outstanding (in shares) | shares								7,311,000
PIPE Purchase Agreement Warrant
Class of Stock [Line Items]
Number of shares of common stock for which warrant is exercisable (in shares) | shares					9,900,990
Exercise price of warrant (in dollars per share) | $ / shares					$ 1.39
Pre-funded warrants outstanding (in shares) | shares								9,900,990
Warrant price (dollars per share) | $ / shares					$ 0.125
PIPE Purchase Agreement Pre-Funded Warrant
Class of Stock [Line Items]
Number of shares of common stock for which warrant is exercisable (in shares) | shares					1,267,897
Discount from stock price (dollars per share) | $ / shares					$ 0.0001
Exercise price of warrant (in dollars per share) | $ / shares					$ 0.0001
Pre-funded warrants outstanding (in shares) | shares								0
Series X Convertible Preferred Stock
Class of Stock [Line Items]
Interest rate percentage							1.00%
Common stock trading price (per share) | $ / shares							$ 22.00
Common stock trading period							30 days
Conversion price (per share) | $ / shares							$ 11.00
Convertible preferred stock (in shares)							91
Outstanding common stock, percentage							9.90%
Outstanding common stock, not to exceed, percentage							19.90%
Percentage of investment owned							50.00%
Maximum working capital line | $							$ 5,000,000
Consideration received | $							15,000,000
Stock issuance costs | $							100,000
Proceeds from sale of equity, net | $							14,900,000
Da Vita Healthcare Partners Inc | Share Issuance, Tranche One
Class of Stock [Line Items]
Proceeds from issuance of convertible preferred stock | $							7,500,000
Da Vita Healthcare Partners Inc | Share Issuance, Tranche Two
Class of Stock [Line Items]
Proceeds from issuance of convertible preferred stock | $		$ 7,500,000	$ 7,500,000
Private Placement | Da Vita Healthcare Partners Inc | Series X Convertible Preferred Stock
Class of Stock [Line Items]
Sale of stock, aggregate consideration authorized | $							15,000,000
Sale of stock, capital proceeds threshold | $							$ 15,000,000
Common stock trading price (in dollars per share) | $ / shares							$ 1,000
Consideration received | $			$ 15,000,000
Private Placement | Da Vita Healthcare Partners Inc | Series X Convertible Preferred Stock | Share Issuance, Tranche One
Class of Stock [Line Items]
Number of shares issued | shares							7,500
Private Placement | Da Vita Healthcare Partners Inc | Series X Convertible Preferred Stock | Share Issuance, Tranche Two
Class of Stock [Line Items]
Number of shares issued | shares		7,500	7,500
Controlled Equity Offering | Cantor Fitzgerald & Co
Class of Stock [Line Items]
Sale of stock, aggregate consideration authorized | $								$ 12,200,000		$ 12,200,000
Number of shares issued | shares	7,500
Consideration received | $	$ 15,135
Stock issuance costs | $	$ 378
Weighted-average selling price (dollars per share) | $ / shares	$ 2.02
Registered Direct Offering
Class of Stock [Line Items]
Number of shares issued | shares					844,613
Common stock trading price (in dollars per share) | $ / shares					$ 1.39
Registered Direct Offering | Registered Direct Offering Warrants
Class of Stock [Line Items]
Discount from stock price (dollars per share) | $ / shares					0.0001
Exercise price of warrant (in dollars per share) | $ / shares					$ 0.0001